BACKGROUND: Rituximab plus chemotherapy has been shown to be effective in patients with advanced-stage, previously untreated follicular lymphoma; nevertheless, most patients will have a relapse. Combination immunotherapy with lenalidomide and rituximab is an immunomodulatory regimen that has shown p...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!